Literature DB >> 35000261

ACE2 and TMPRSS2 immunolocalization and oral manifestations of COVID-19.

Gi Cheol Park1, Soo-Young Bang2, Hyoun Wook Lee3, Kyung Un Choi4, Ji Min Kim2, Sung-Chan Shin2, Yong-Il Cheon2, Eui-Suk Sung5, Minhyung Lee5, Jin-Choon Lee5, Hyung-Sik Kim6, Byung-Joo Lee2.   

Abstract

OBJECTIVES: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) entry into the host cells depends on the expression of angiotensin-converting enzyme 2 (ACE2) and transmembrane protease serine 2 (TMPRSS2). We investigated the distribution of ACE2- and TMPRSS2-expressing cells in various oral tissues to identify the underlying mechanism of oral manifestations in patients with coronavirus disease 2019.
SUBJECTS: We analyzed the expression patterns of ACE2 and TMPRSS2 in the oral mucosa (tongue, palate, and buccal mucosa), trigeminal ganglion, vessels, and salivary glands of 9 Sprague-Dawley rats using immunohistochemistry and immunofluorescence.
RESULTS: ACE2 and TMPRSS2 were strongly expressed in the intermediate layer of the squamous epithelia of tongue papillae and buccal mucosa. ACE2- and TMPRSS2-positive cells were observed in the taste buds of the tongue. Additionally, ACE2 and TMPRSS2 were co-expressed in the ductal epithelium and acinar cells of salivary glands. Furthermore, both ACE2 and TMPRSS2 were stained in the neuronal cell body of trigeminal ganglia, but not in Schwann cells. Moreover, ACE2 and TMPRSS2 were expressed in capillaries, but not in venules/arterioles.
CONCLUSIONS: SARS-CoV-2 can spread the suprabasal area of squamous epithelia of the oral mucosa, invades taste bud, trigeminal nerve, parotid gland, and microvessel, resulting in oral manifestations.
© 2022 Wiley Periodicals LLC.

Entities:  

Keywords:  ACE2; COVID-19; SARS-CoV-2; TMPRSS2; oral manifestation

Year:  2022        PMID: 35000261     DOI: 10.1111/odi.14126

Source DB:  PubMed          Journal:  Oral Dis        ISSN: 1354-523X            Impact factor:   3.511


  2 in total

1.  An update on oral clinical courses among patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection: A clinical follow-up (a prospective prevalent cohort) study.

Authors:  Heron Gezahegn Gebretsadik
Journal:  PLoS One       Date:  2022-10-21       Impact factor: 3.752

Review 2.  COVID-19 and olfactory dysfunction: a looming wave of dementia?

Authors:  Leslie M Kay
Journal:  J Neurophysiol       Date:  2022-07-27       Impact factor: 2.974

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.